Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravesical Alkalized Lidocaine for the Treatment of Overactive Bladder (OAB), a Randomized, Double-blinded Controlled Trial

NCT00427648 is registered in ClinicalTrials.gov with Frank Tu as lead sponsor.

NCT NCT00427648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00427648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravesical Alkalized Lidocaine for the Treatment of Overactive Bladder (OAB), a Randomized, Double-blinded Controlled Trial
Lead sponsor
Frank Tu
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2006
Completion date
May 31, 2010
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder